The global lactase market is projected to reach USD 336 million by 2027, at a CAGR of 6.3%, in terms of value, between 2022 and 2027. It is estimated to be valued at USD 247 million in 2022. Lactose is a type of sugar found in milk and other dairy products, lactase is an enzyme that helps in breaking down the milk sugar lactose into simple sugars, namely glucose and galactose. Factors, such as increasing demand for lactose-free and rising product development & innovations in other application areas like pharmaceutical, dietary supplements, and infant nutrition are expected to boost the demand for lactase on a global level. Key players in the market are introducing new food products like lactose-free cream, ice cream, and milk alternatives to address the growing lactase-deficient population.
The lactase market is expected to experience significant growth in the coming years, driven by increasing demand for lactose-free and low-lactose dairy products. Lactase is an enzyme that breaks down lactose, a type of sugar found in milk and other dairy products, into simpler sugars that can be easily digested by people who are lactose intolerant.
One of the main drivers of growth in the lactase market is the growing awareness of lactose intolerance among consumers. Lactose intolerance is a condition in which the body is unable to digest lactose, leading to symptoms such as bloating, gas, and diarrhea. As more people become aware of this condition and the benefits of lactose-free and low-lactose dairy products, the demand for lactase is expected to increase.
In addition, the growing trend towards healthier eating habits is also driving growth in the lactase market. Many consumers are turning to dairy-free and plant-based alternatives to traditional dairy products, and lactase is an essential ingredient in many of these products.
The market for lactase is also being driven by advancements in technology, which have made it easier and more cost-effective to produce lactase on a large scale. This has led to an increase in the number of companies entering the lactase market, as well as a decrease in the price of lactase.
North America is the largest region with a significant CAGR in the lactase market. A huge lactose-intolerant consumer base in the region creates a growth opportunity for the lactase market in North America. American Academy of Pediatrics (AAP) recommends that people with lactose intolerance must not be encouraged to avoid milk or any dairy product as it provides necessary nutrients like calcium to the body. This creates a lucrative opportunity for marketing different lactose-free products to cater to the growing lactose-intolerant population in North America.
With the increasing health awareness among consumers, the willingness to pay for supplements and food & beverage products has witnessed tremendous growth in recent years. Additionally, growing vegan and flexitarian diet also contributes to the rising demand for lactose-free products in the region, impacting the need for lactase enzyme.
Key Market Players:
Key players in the lactase market include CHR. Hansen Holdings A/S (Denmark), Kerry Group plc. (Ireland), Koninklijke DSM N.V. (the Netherlands), Novozymes A/S (Denmark), Merck KGaA (Denmark), IFF (US), Amano Enzyme (Japan), Advanced Enzyme Technologies (India), Novact Corporation (US), Antozyme Biotech Pvt. Ltd (India), Nature Biosciences Pvt. Ltd (India), Aumgene Biosciences (India), Creative Enzymes (US), Biolaxi Enzymes Pvt. Ltd (India), Enzyme Biosciences Pvt. Ltd (India), Infinita Biotech (India), Mitushi Biopharma (India), Oenon Holdings Inc. (Japan), Ultreze Enzymes (India), and Senson (Finland)
